The Business of Cannabis Awards Return to London for a Third Year
The Business of Cannabis Awards 2026 is returning to London for its third consecutive year to celebrate the best and brightest figures in the European cannabis industry.
The Business of Cannabis Awards 2026 is returning to London for its third consecutive year to celebrate the best and brightest figures in the European cannabis industry.
Multi-state operators, or MSO’s, have long represented the biggest and most influential cannabis players in North America. Yet, as that market matures and expansion opportunities dwindle a new trend is emerging – the rise of ‘multi-country operators’ (MCOs).
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines, is proud to announce its entry into Switzerland through a strategic partnership with Dascoli Pharma AG, a Switzerland-based pharmaceutical company specializing in the supply, distribution, and professional training of medical cannabis.
SOMAÍ Pharmaceuticals (“SOMAÍ”), a fully vertically integrated Multi-Country Operator (MCO) in the global medical cannabis markets, is proud to announce the Mint Oral Solutions product line launch in Australia, Germany, and the UK.
UK medical cannabis patients are facing multiple challenges that are preventing the adoption of the legal market.
Written by Michael Sassano, CEO, Somai Pharmaceuticals Recently, I have become more optimistic about the global landscape of medical cannabis and the direction in which major regulatory agencies are heading.
Written by Michael Sassano, CEO, Somai Pharmaceuticals On January 12, the United States Department of Health and Human Services (HHS) released a letter and supporting 252-page document that will make it extremely difficult for the Drug Enforcement Agency (DEA) to ignore its findings on the benefits of cannabis and all but ensuring that the U.S.
Last month, Portugal’s government announced plans to establish a working group to explore the regulation of adult-use cannabis, with a conclusion expected by the end of the year.
Last week, Germany took the first step towards wholesale cannabis legalisation after the federal cabinet waved through the long-awaited draft bill for Pillar 1 of its strategy.